chrisvoncsefalvay/vaers-outcomes huggingface dataset:
client complained of dizziness and nausea after receiving 1st Pfizer Covid Vaccine.  At 1000 client reported to EMTs feeling light headed and nauseous. Per client had not had any breakfast or hydrated today. EMT gave client water and crackers. Per client no allergy to any of the ingredients. First vitals: blood pressure 130/70, pulse 80, oxygen 98%. Client's parent here, states client takes medication for depression, unable to recall name and birth control. Vitals at 1010: blood pressure 110/70, pulse 80, oxygen 98%. Per client still nauseous, light headedness improving. 1015 vitals: blood pressure 110/70, pulse 79, oxygen 97%. Mild nausea, light headed resolved. Vitals at 1020: blood pressure 108/70, pulse 78, oxygen 98%. Per client all symptoms resolved. Client given ER precautions and advised to consult with provider prior to second dose. Parent driving client home. Client left facility with steady gait at 1022.
itchy rash on arms and legs; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itchy rash on arms and legs) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced RASH PRURITIC (itchy rash on arms and legs). At the time of the report, RASH PRURITIC (itchy rash on arms and legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Took 1st vaccine back in April, but for certain reasons did not take the second vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Took 1st vaccine back in April, but for certain reasons did not take the second vaccine.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Took 1st vaccine back in April, but for certain reasons did not take the second vaccine.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Took 1st vaccine back in April, but for certain reasons did not take the second vaccine.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported.  No Treatment medications were reported.   Reporter did not allow further contact
Shortly after receiving vaccine (about 5 minutes), pt complained about difficulty breathing. I went to check on her and she appeared pale and seemed very drowsy and unresponsive to questions. She continued to complain about dizziness and nausea. Her parents grabbed some water for her and still there was no improvement. I called 911 to report the symptoms and was advised to administer EpiPen. When asked if her breathing improved, she nodded yes, but she did not appear to have improved. She continued to be unresponsive to questions and appeared extremely drowsy. Within 15 minutes, the ambulance arrived.
Itching all over.  Started about 24 hours after vaccine and lasted about 12 hours.  Very similar to the reaction I get from vicodin (although the vicodin itching only lasts a couple hours.)
TDAP administered, mother called to report patient woke up 9-29-11 at 0300 complaining of nausea; fever vomited while talking to mom. At 0730 when I talked with mom the student was sleeping.
Information has been received from an LPN concerning a female in her 70's who on 10/26/01 was vaccinated with a dose of pneumococcal vaccine 23 polyvalent. On approx. 10/26/01, the pt experienced injection site reaction of the upper arm, swollen, red, inflammed, "baseball size" area with weakness, nausea, dizziness and a red rash at the neck line. She was treated with Benadryl. Subsequently, the pt recovered. Upon internal review, injection site reaction was considered an "Other Important Medical Events". The LPN also reported that a female in her 80's experienced injection site reaction, weakness, nausea and dizziness while on therapy with pneumococcal vaccine 23 polyvalent (see WAES 01106326). Additional information has been requested.
Mild swelling on my right side of my neck and left inside elbow. It started to go away and then came back after the second dose. I am still dealing with this at this time.
Patient states her arm is very sore and she has less range of motion since the Flu Vaccine was administered on 10/18/21. She states that the vaccine "seemed high" to her.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 26-MAR-2015, the patient was vaccinated with improperly stored M-M-R II lot # J014872 and 21-NOV-2015 (unknown strength and route). Concomitant medications were not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous case reported by a patient family member or friend, describes the occurrence of tremor (hand shaking) and fatigue (after the third shot Sep 2021) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. September 2021, patient received the third dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the first and second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced tremor (hand shaking) and fatigue (after the third shot Sep 2021). At the time of the report, tremor (hand shaking) and fatigue (after the third shot Sep 2021): unresolved. No concomitant medication or treatment information provided. It has been one whole year without any improvement.
extremely ill; had a severe case of COVID-19; This is a spontaneous report from a contactable consumer A 63-year-old male patient (consumer husband) received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19-19 mRNA VACCINE, Formulation: Solution for injection, (Batch/Lot number was not reported)) via an unspecified route of administration on Mar2021 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The caller speaking on behalf of her husband (patient). Caller stated that her husband received the first dose of the Pfizer-BioNTech COVID-19 Vaccine in last March. Seven days later, he "became extremely ill", was brought to the hospital, had a severe case of COVID-19 and was in intensive care. Caller mentioned that his doctors and healthcare providers agreed that he should not get revaccinated until 3-4 months after. Caller stated that it would be around this time and asked if he needs to restart the vaccination series given. The outcome of the events was unknown.  The lot number for the vaccine (BNT162B2), was not provided and will be requested during follow-up.
w/in 1 wk of DTP vax pt having stomach cramps; the 3rd consecutive nite took to ER; was told having sx (myoclonic seizures or infantile spasms); pt has trouble w/equalibrium; poss encephalopathy; pt has learning disability & ataxia;
Increasing shoulder pain with movement. Limited range of motion. Progressed to where I could not raise my arm above shoulder level. Has improved with medication to the point of chronic discomfort, however I am unable to sleep on that side and still do not have full range of motion.
RED HARD NODULE AT SITE OF INJECTION. TREATMENT INCLUDED MEDROL, KEFLEX, AND WAS EXCISED AT LATER DATE.
short of breath; chest pain; she had a blood clot and was diagnosed with a blood clot/diagnosed with DVT; Red splotches on leg; This is a spontaneous report from a contactable Nurse. A 62-year-old female patient received first dose of BNT162B2 (BNT162B2), via an unspecified route of administration, administered in Arm Right on an unspecified date (Batch/Lot Number: EW0150) as SINGLE DOSE for covid-19 immunization. Medical history included she had a blood clot after surgery 100 pounds ago, around 18 years ago, she had the heart attack at age 41 and thrombophlebitis from an unknown date and unknown if ongoing. Concomitant medications included aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]) taken for cardiac disorder from an unspecified start date and ongoing.  The patient experienced she had a blood clot and was diagnosed with a blood clot/diagnosed with DVT on 10Apr2021 and red splotches on leg on 09Apr2021. She states she got the vaccine on Thursday 08Apr2021. She confirms that the painful red splotches showed up on 09Apr2021. The blood Clot was diagnosed on the 10Apr2021. She states that the doctors put her on Lovenox. She states that it is only significant if she gets short of breath and/or has chest pain. If it travels then it is significant. She states that her doctor said she had a good sized clot, but she didn't ask specifics. Outcome of the event was not recovered.; Sender's Comments: On the basis of the available information, the reported event DVT would seem most likely related to underlying medical conditions which is not related to BNT162B2.
Apneic episodes starting 12/2/6  --> admitted to medical center but transferred to another Hospital ---> diagnosed with GERD and central apnea.  08/27/2007 MR received for DOS 12/06-12/2006 for an admitting DX of Apnea, Bradycardia, probable Reflux after being transfered from another facility following several episodes apnea with desaturations.  In the ER infant had several episodes of apnea >20seconds with hypoxia  and bradycardia. Infant had resolution of symptoms on Prevacid and Reglan.  Placed on home apnea monitor after D/C. D/C DX:  Gastroesphageal Reflux Disease.
Injection site red and painful. Looking at the area it was toward the back of the left upper arm. A dime sized red/raw wound. No discharge, pus, or itchiness. Counseled patient on how to take care of the area and follow up on 10/30/2017.
I had heart flutter and my heart rate went up to  150 per minute. I was prescribe diltiazem 30 MG. I take every 8 hours.
This case was reported by a physician via a sales representative and described the occurrence of stinging at the injection site in a subject of unspecified age and gender who was vaccinated with TWINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of TWINRIX. At an unspecified time after vaccination with TWINRIX, the subject experienced stinging and burning at the injection site. This was also reported to be a product complaint as the reporter felt the events were related to a quality issue with the TWINRIX injection. The outcome of the events was unspecified. It was reported that 10 subjects (including this one) experienced burning and stinging at the injection site following administration of TWINRIX from the same lot. Linked cases include: A0752060A, A0752087A, A0752088A, A0752089A, A0752090A, A0752091A, A0752092A, A0752093A and A0752095A.
This spontaneous report as received from a certified medical assistant refers to a 14 year old male patient. Pertinent medical history, drug reactions or allergies were not reported. On an unknown date the patient was vaccinated with a dose of GARDASIL (dose, route number, route, lot number and expiration date were unspecified). No concomitant therapies were reported. Since an unspecified date the patient developed nausea and dizziness so the patient's mother called the physician's office. The treatment given for the adverse events was not reported. The outcome of the nausea and dizziness was reported as not recovered. The relatedness between the events and GARDASIL was not reported. Additional information has been requested.
Got shingles after jab/suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got shingles after jab/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 09-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he/she experienced shingles after received Shingles vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
The patient developed a rash on her face, ears, backside and arm. The patient was treated with Prednisone. On 11/12 the rash is better.
On 4/9 pt developed severe headache, vision changes, slurred speech. Taken to the hospital and scans confirmed he had a Bilateral intracranial vertebral artery dissections with occlusion of the left VA and stenosis of the right, causing multiple small left cerebellar hemispheric, thalamic and occipital lobe ischemic infarctions and small amount of left frontal subarachnoid hemorrhage. Pt was admitted to the ICU. Currently residing on the Neuro floor at NMH, NIH is 0.
Patient received a more potent dose than he should have due to the vaccine not being diluted before use. The patient received a dose of 0.2mL but, again, undiluted. Now, 24 hours later, patient has not had any adverse reactions.
Horrible pain all over the body, migraine, weakness, slept on and off for 5 days.  Pain was at a 10 even after pain medication and iv fluids.
That same night there were chills and in my legs I felt bubbles, the next day on Saturday I was very tired and I could not even lift my arms or want to walk because everything hurt, for that same night my body began to shake at times. The next day was Sunday. I felt worse, I could not stay standing because I felt that inside my body was shaking and an hour later my arms and legs began to shake and I could not control them, my husband took me to the hospital and there they did several studies, I was 10 days in Hospital
Worsening left shoulder joint pain anteriorly in the days following administration. Pain is described as aching pain. No radiation of pain, no rash or bump present. No neurological or skin changes. No changes in ROM of extremity, no crepitation or swelling of joint noted. The member is breastfeeding and currently is not taking analgesics.
8-12 hours after vaccine administration I experienced extreme left breast pain, Upon exam breast appears swollen, red, with striations. severe muscle aches, headache, low blood pressure.
Fatigue, tingling in lips, face, neck, hands. Dryness in lips and hands. Soreness at injection site. Temperature 99.8
Today November 30, 2022 patient contacts us and verbalizes by phone that a week after administering the vaccine she presents pain in the lymph nodes and swelling, abdominal pain right side near the liver, yellowish tongue and sore throat.
Patient received Pfizer-BioNTech Covid-19 vaccine, first injection, in the afternoon of Tuesday, 1/19/2021 - administered by pharmacy staff.  All residents and staff of the facility were vaccinated (except one resident). Wednesday afternoon (1/20/2021), patient was noted to have a open area on his 3rd left toe with digital edema and blackening of toe, 2nd toe had a fluid filled blister as did area superior to left medial knee.  There was also an open area inferior to left medial knee. Bruising or blackened areas to 3rd left toe and bottom of left foot (pad below toes 1-3).  Patient was placed on Keflex 500 mg BID for 10 days, Clotrimazole 1% topical cream for ring worm middle of left foot, and ammonium lactate 12% lotion for dry skin.  By Saturday, 1/23/2021, multiple blisters had erupted on patient's left medial knee area and 4th left toe.  Some of the prior blisters were now gone, but new blisters were larger.  On Thursday, 1/28/2021, patient now has blisters and open areas on bilateral feet, legs, and hands.  He has a red rash on his right lower leg just superior to the medial ankle.  Patient was placed on a 10 mg Medrol Dose Pak.   There have been no changes to the patient's diet or medications.  Patient is confined to the facility due to dementia.  He goes from his bedroom to a sitting area, right outside of his bedroom door.  He ambulates with assistance using a cane, only to the bathroom in his room.  He has a private room.
This spontaneous case was reported by a physician and describes the occurrence of ageusia (loss of taste), pain (general body aches), nausea and vomiting in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 3, 2021, patient experienced ageusia (loss of taste), pain (general body aches), nausea and vomiting. At the time of the report, ageusia (loss of taste), pain (general body aches), nausea) and vomiting outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information.
40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   This case contains information for the 16th of 40 adult patients.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
It was reported post vaccine's pt experienced tightness in the same area when she lays on that side (L arm)pt reports its not painful just tight.
This spontaneous report as received from a registered nurse, refers to a 4 month old female patient, who on 21-AUG-2013 was vaccinated with a dose of ROTATEQ (lot # 672244/1847AA, exp date 17-AUG-2013) (2 ml, oral route). Concomitant therapy was not reported. No adverse effect reported. Additional information has been requested.
itching, redness, swelling, warmth at injection site  warm compresses applied at doctor's instruction -- no immediate effect
Child's left lower deltoid red with swelling. Started on 6/29/05 AM, cool packs with Benadryl given.
Injection site has inflamed and resumed itching again,  12 days after initial injection.  I once again have a large red mark at the injection sight and intermittent itching.
I had chills the night of receiving vaccine shot.  I had a fever the next day along with large swollen itchy raised bump (about 5? in length) on the injection spot .  The fever lasted about 24 hours.  The swollen itchy bump still continues (this is my 3rd day after shot).   Headache and sinus pain has also persisted since 2nd day.
got like Brutal pain in the areas; hard to sleeping; got a like a rash, close to my under arm and on my lower back on the right side and it is lot of red/not directly on the arm pit, the rash close to it; getting lot of pain around the rash; Red dots, dark red and then the area around it turn orange or light red; painful like a burn on both of my arm pits more toward the back with 2 of those dots almost in the back going toward my back bone kind of in the middle; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program. A 76-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EC8302), dose 2 via an unspecified route of administration on 17Feb2021 (at the age of 76years old) as dose 2, single for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine patient received BNT162B2 (Batch/Lot Number: EK4176), dose 1 via an unspecified route of administration on 27Jan2021 (at the age of 76years old) as dose 1, single for Covid-19 immunisation and had no side effects after the first dose of the vaccine. After 2nd dose, the patient reported no other side effects at this time other than red dots, dark red and then the area around it turned orange or light red and its painful like a burn on both of my arm pits more toward the back with 2 of those dots almost in the back going toward his backbone kind of in the middle in Jun2021. When he tried to sleep, he lay on it and wait an hour before the pain goes away. On 14Jun2021, the patient got a like a rash, close to his under arm and on my lower back on the right side and it was lot of red, it was not directly on the arm pit, the rash close to it. On 14Jun2021, the patient got the brutal pain in the areas and had hard to sleeping, and that was why he used this medication cream NEOSPORIN (start date: 17Jun2021), and it didn't do the great result. He was getting lot of pain around the rash and it was turning red, and it had red dot, he thought it will help but it didn't help. The patient didn't think it was serious, but it was getting painful. The patient also took ASPIRIN, it was a very low dose, he told to reduce with the pain, its 81 mg and confirmed it as treatment to treat the adverse effect. Therapeutic measures (NEOSPORIN and ASPIRIN) for all the events except hard to sleeping. The outcome for got a like a rash, close to my under arm and on my lower back on the right side and it is lot of red/not directly on the arm pit, the rash close to it; red dots, dark red and then the area around it turn orange or light red; and getting lot of pain around the rash was not recovered; and for rest all was unknown.  Follow-up attempts are completed. No further information is expected.
Pt came to ER c/o SOB, fever, chills, cough, headache, weakness, onset 3 days prior.   covid positive on 7/17/21.